Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09LEK
|
|||
Former ID |
DNC005645
|
|||
Drug Name |
4-(5-Phenyl-oxazol-2-ylamino)-benzenesulfonamide
|
|||
Synonyms |
GW572399X; 4-[(5-phenyl-1,3-oxazol-2-yl)amino]benzenesulfonamide; 2-Anilino-5-aryloxazole 15; AC1NS7RK; CHEMBL194062; BDBM5854; HMS3303D13; HMS3305L11; NCGC00242064-01; AB01092072-01
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H13N3O3S
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=C(C=C3)S(=O)(=O)N
|
|||
InChI |
1S/C15H13N3O3S/c16-22(19,20)13-8-6-12(7-9-13)18-15-17-10-14(21-15)11-4-2-1-3-5-11/h1-10H,(H,17,18)(H2,16,19,20)
|
|||
InChIKey |
OKFOIEMZTIOWQH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10;48(5):1610-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.